×
News Home

Is Pfizer Inc. (PFE) Stock Trading Below Fair Value?

Monday, July 12, 2021 03:04 PM | InvestorsObserver Analysts
Is Pfizer Inc. (PFE) Stock Trading Below Fair Value?

PFE receives a strong valuation score of 79 from InvestorsObserver's analysis. Our proprietary scoring system considers the overall health of the company by looking at the stock's price, earnings, and growth rate to determine if it represents a good value. PFE holds a better value than 79% of stocks at its current price. Investors who are focused on long-term growth through buy-and-hold investing will find the Valuation Rank especially relevant when allocating their assets.

Valuation Rank - 79
PFE gets a 79 Valuation Rank today. Find out what this means to you and get the rest of the rankings on PFE!

Metrics Analysis

PFE has a trailing twelve month Price to Earnings ([PE](https://www.investorsobserver.com/learning-center/stock-basics/what-is-a-p-e-ratio)) ratio of 19.8. The historical average of roughly 15 shows a average value for PFE stock as investors are paying fair share prices relative to the company's earnings. PFE's average trailing PE ratio shows that the firm has been trading around its fair market value recently. Its trailing 12-month earnings per share (EPS) of 1.97 justifies the stock's current price. However, trailing PE ratios do not factor in the company's projected growth rate, resulting in many newer firms having high PE ratios due to high growth potential enticing investors despite inadequate earnings. PFE's 12-month-forward PE to Growth ([PEG](https://www.investorsobserver.com/learning-center/stock-basics/what-is-a-peg-ratio)) ratio of 1.39 is considered a poor value as the market is overvaluing PFE in relation to the company's projected earnings growth due. PFE's PEG comes from its forward price to earnings ratio being divided by its growth rate. A PEG ratio of 1 represents a perfect correlation between earnings growth and share price. Due to their incorporation of more fundamentals of a company's overall health and focusing on the future rather than the past, PEG ratios are one of the most used valuation metrics by analysts today.

Summary

PFE' has a weak valuation at its current share price on account of a overvalued PEG ratio despite strong growth. PFE's PE and PEG are worse than the market average leading to a below average valuation score. [Click Here to get the full Stock Score Report on Pfizer Inc. (PFE) Stock.](https://www.investorsobserver.com/symbols/pfe)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App